Clinical Trials Browser

Phase 1/2 × Prostatic Diseases × Androgen Antagonists × Clear all

NCT03543189 2026-04-01

Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy

Phase 1/2 Active not recruiting

Prostatic Diseases, Prostatic Neoplasms